Journey Medical extends term loan maturity to June 2028 and lowers revenue threshold for deferred repayment to $60M

Journey Medical Corp

Maturity of $25M Term Loan extended from Dec 27, 2027 to June 27, 2028.
If trailing 12-month revenue > $60M as of Dec 31, 2025 (down from $70M), principal repayment deferred to Feb 2027.
Without revenue trigger, quarterly repayment begins Feb 2026 at 7.5% of principal.
With revenue trigger, quarterly repayment at 10% starting Feb 2027 (down from 15%).
All $25M drawn; agreement amended with SWK Funding LLC.

item 1.01item 2.03

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.